Search all resources on this page or select a tab to see publications, videos, audio, collections of related resources and more.
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021.
This strategy aims to improve the skills of the alcohol and other drug (AOD) workforce and prepare them for the future.
This document is a response to the findings of the National Ice taskforce in 2015. This report provides a comprehensive assessment of the NIAS.
This report outlines the findings of a randomised controlled trial (RCT) conducted by the Department of Health. The RCT explored whether a letter designed with behavioural insights principles would help GPs reflect on their opioid prescribing.
The Real Time Prescription Monitoring (RTPM) Privacy Impact Assessment (PIA) was conducted to ensure the Nation Data Exchange (NDE) system contained the appropriate obligations and protections in relation to the collection and storage of individual personal information.
This certificate of compliance, signed by Secretary Brendan Murphy, certifies that the safe and effective prescription opioids campaign complies with relevant guidelines and policies.Part of a collection: Certification statements for advertising campaigns
This webinar hosted by Prof. Michael Kidd AM focuses on the impact of the revised Opioid prescribing changes from 1 June 2020. The expert panel will provide information and answer participants’ questions.
This framework’s aim is that all Australians seeking alcohol and other drug treatment can access high quality treatment appropriate to their needs, when and where they need it. It includes principles for effective treatment, monitoring and evaluation.
This report presents trends data of the Australian Secondary Students' Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs, 1996–2017.
This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs.
This 2014 report describes the alcohol and other drug (AOD) treatment system and funding processes in Australia. It provides options for future funding that respond to the needs of individuals, families and communities.
This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.
A summary of the major items discussed at the fifth MDAF meeting.Part of a collection: Ministerial Drug and Alcohol Forum (MDAF) communiques
Every 3 years 20,000 to 30,000 secondary students aged between 12 and 17 take part in a national survey of adolescent substance use in Australia. These reports present the findings from the 2017 surveys.